Biogen | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.25B 40M 2025-06
Acadia Pharmaceuticals USD 126.37M 3.71M 2025-03
ALKERMES USD 153.87M 17.83M 2025-06
Amgen USD 1.69B 191M 2025-03
Bayer EUR 3.71B 628M 2025-03
Biogen USD 583.8M 11.3M 2025-06
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
Incyte USD 331.02M 5.33M 2025-06
Merck USD 2.63B 104M 2025-06
Moderna USD 230M 18M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06
Pfizer USD 3.01B 1.27B 2025-03
PTC Therapeutics USD 161.92M 77.24M 2025-03
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Sanofi EUR 2.63B 408M 2025-06
Sanofi EUR 1.24B 1.44B 2024-12
Sarepta Therapeutics USD 133.63M 30.24M 2025-03
Teva Pharmaceutical Industries USD 959M 40M 2025-06
Ultragenyx Pharmaceutical USD 87.8M 5.3M 2025-03
United Therapeutics USD 212.5M 42.4M 2025-06
Vertex Pharmaceuticals USD 396.4M 18.8M 2025-03


Biogen 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.